Authors:
TU SM
PAGLIARO LC
BANKS ME
AMATO RJ
MILLIKAN RE
BUGAZIA NA
MADDEN T
NEWMAN RA
LOGOTHETIS CJ
Citation: Sm. Tu et al., PHASE-I STUDY OF SURAMIN COMBINED WITH DOXORUBICIN IN THE TREATMENT OF ANDROGEN-INDEPENDENT PROSTATE-CANCER, Clinical cancer research, 4(5), 1998, pp. 1193-1201
Authors:
TU SM
PAGLIARO LC
BANKS ME
AMATO RJ
MILLIKAN RE
BUGAZIA NA
MADDEN T
NEWMAN RA
LOGOTHETIS CJ
Citation: Sm. Tu et al., PHASE-I STUDY OF SURAMIN COMBINED WITH DOXORUBICIN IN THE TREATMENT OF ANDROGEN-INDEPENDENT PROSTATE-CANCER, Clinical cancer research, 4(5), 1998, pp. 1193-1201
Authors:
GARTEIZ DA
MADDEN T
BECK DE
HUIE WR
MCMANUS KT
ABBRUZZESE JL
CHEN W
NEWMAN RA
Citation: Da. Garteiz et al., QUANTITATION OF DOLASTATIN-10 USING HPLC ELECTROSPRAY IONIZATION MASS-SPECTROMETRY - APPLICATION IN A PHASE-I CLINICAL-TRIAL/, Cancer chemotherapy and pharmacology, 41(4), 1998, pp. 299-306
Citation: Js. Phinney et al., PSYCHOLOGICAL VARIABLES AS PREDICTORS OF PERCEIVED ETHNIC DISCRIMINATION AMONG MINORITY AND IMMIGRANT ADOLESCENTS, Journal of applied social psychology, 28(11), 1998, pp. 937-953
Authors:
MENDELSOHN ME
ABRAMSON DH
MADDEN T
TONG W
TRAN HT
DUNKEL IJ
Citation: Me. Mendelsohn et al., INTRAOCULAR CONCENTRATIONS OF CHEMOTHERAPEUTIC-AGENTS AFTER SYSTEMIC OR LOCAL-ADMINISTRATION, Archives of ophthalmology, 116(9), 1998, pp. 1209-1212
Citation: Wr. Huie et al., HIGH-PERFORMANCE CAPILLARY ELECTROPHORESIS MEASUREMENT OF DOLASTATIN-10, Journal of chromatography B. Biomedical sciences and applications, 693(2), 1997, pp. 451-461
Citation: Ra. Newman et al., HPLC MEASUREMENT OF THE NOVEL NONNUCLEOSIDE ANTI-HIV AGENT, (-A()DIHYDROCALANOLIDE), Journal of liquid chromatography & related technologies, 20(4), 1997, pp. 651-659
Authors:
KORNBLAU SM
ESTEY E
MADDEN T
TRON HT
ZHAO S
CONSOLI U
SNELL V
SANCHEZWILLIAMS G
KANTARJIAN H
KEATING M
NEWMAN RA
ANDREEFF M
Citation: Sm. Kornblau et al., PHASE-I STUDY OF MITOXANTRONE PLUS ETOPOSIDE WITH MULTIDRUG BLOCKADE BY SDZ PSC-833 IN RELAPSED OR REFRACTORY ACUTE MYELOGENOUS LEUKEMIA, Journal of clinical oncology, 15(5), 1997, pp. 1796-1802
Authors:
JOHANSEN MJ
MADDEN T
MEHRA RC
WOOD JG
RONDON G
BROWNE V
NEWMAN RA
CHAMPLIN RE
Citation: Mj. Johansen et al., PHASE-I PHARMACOKINETIC STUDY OF MULTICYCLE HIGH-DOSE CARBOPLATIN FOLLOWED BY PERIPHERAL-BLOOD STEM-CELL INFUSION IN PATIENTS WITH CANCER, Journal of clinical oncology, 15(4), 1997, pp. 1481-1491
Citation: T. Karunakaran et al., ISOLATION AND CHARACTERIZATION OF A HEMIN-REGULATED GENE, HEMR, FROM PORPHYROMONAS-GINGIVALIS, Journal of bacteriology, 179(6), 1997, pp. 1898-1908
Authors:
ANDERSSON BS
HAI T
MADDEN T
CAGNONI P
JONES R
BRUTON J
MARTINKA S
HOLBERT K
GIRALT S
PRZEPIORKA D
LENNON S
SPILKER B
GIAN V
WINGARD J
TARANTOLO S
KASHYAP A
FORMAN S
CHAMPLIN RE
Citation: Bs. Andersson et al., ALLOGENEIC TRANSPLANTATION IN ADVANCED HEMATOLOGIC MALIGNANCIES AFTER-IV BUSULFAN CYCLOFOSFAMIDE (BUCY), Blood, 90(10), 1997, pp. 1003-1003
Citation: T. Madden et al., ORGANIC-ACID EXCRETION BY STREPTOMYCES-LIVIDANS TK24 DURING GROWTH ONDEFINED CARBON AND NITROGEN-SOURCES, Microbiology, 142, 1996, pp. 3181-3185
Authors:
ABBRUZZESE JL
MADDEN T
SUGARMAN SM
ELLIS AL
LOUGHLIN S
HESS KR
NEWMAN RA
ZWELLING LA
RABER MN
Citation: Jl. Abbruzzese et al., PHASE-I CLINICAL AND PLASMA AND CELLULAR PHARMACOLOGICAL STUDY OF TOPOTECAN WITHOUT AND WITH GRANULOCYTE-COLONY-STIMULATING FACTOR, Clinical cancer research, 2(9), 1996, pp. 1489-1497
Authors:
KUDELKA AP
TRESUKOSOL D
EDWARDS CL
FREEDMAN RS
LEVENBACK C
CHANTARAWIROJ P
DELEON CG
KIM EE
MADDEN T
WALLIN B
HORD M
VERSCHRAEGEN C
RABER M
KAVANAGH JJ
Citation: Ap. Kudelka et al., PHASE-II STUDY OF INTRAVENOUS TOPOTECAN AS A 5-DAY INFUSION FOR REFRACTORY EPITHELIAL OVARIAN-CARCINOMA, Journal of clinical oncology, 14(5), 1996, pp. 1552-1557
Authors:
HOLMES FA
MADDEN T
NEWMAN RA
VALERO V
THERIAULT RL
FRASCHINI G
WALTERS RS
BOOSER DJ
BUZDAR AU
WILLEY J
HORTOBAGYI GN
Citation: Fa. Holmes et al., SEQUENCE-DEPENDENT ALTERATION OF DOXORUBICIN PHARMACOKINETICS BY PACLITAXEL IN A PHASE-I STUDY OF PACLITAXEL AND DOXORUBICIN IN PATIENTS WITH METASTATIC BREAST-CANCER, Journal of clinical oncology, 14(10), 1996, pp. 2713-2721
Authors:
WALL SM
JOHANSEN MJ
MOLONY DA
DUBOSE TD
JAFFE N
MADDEN T
Citation: Sm. Wall et al., EFFECTIVE CLEARANCE OF METHOTREXATE USING HIGH-FLUX HEMODIALYSIS MEMBRANES, American journal of kidney diseases, 28(6), 1996, pp. 846-854
Authors:
JOHANSEN MJ
WALL S
JAFFE N
GARDNER M
NEWMAN RA
MADDEN T
Citation: Mj. Johansen et al., HIGH-EFFICIENCY DIALYSIS EFFECTIVELY REMOVES METHOTREXATE IN CANCER-PATIENTS WITH RENAL-FAILURE, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 35-35
Authors:
TRAN HT
MADDEN T
FELIX E
GARDNER M
PETROPOULOS D
PRZEPIORKA D
CHAN KW
Citation: Ht. Tran et al., EVALUATION OF A PREPARATIVE REGIMEN CONTAINING ADJUSTED-DOSE BUSULFANWITH STEM-CELL SUPPORT FOR THE TREATMENT OF ADVANCED HEMATOLOGIC MALIGNANCIES IN PEDIATRIC, Blood, 88(10), 1996, pp. 3767-3767
Authors:
ANDERSSON BS
MADDEN T
STANFIELD L
HU W
CHOW DSL
BLUME K
WILLIAMS TE
VAUGHAN WP
CHAMPLIN RE
Citation: Bs. Andersson et al., PRETRANSPLANTATION CONDITIONING THERAPY WITH IV BUSULFAN CYCLOPHOSPHAMIDE (BUCY) - A PHASE-I STUDY/, Blood, 88(10), 1996, pp. 2372-2372
Authors:
BICK RL
LAUGHLIN HR
COHEN BM
STAUB AJ
MADDEN T
TOOFANIAN A
Citation: Rl. Bick et al., FETAL WASTAGE SYNDROME DUE TO BLOOD PROTEIN PLATELET DEFECTS - RESULTS OF PREVALENCE STUDIES AND TREATMENT OUTCOME WITH LOW-DOSE HEPARIN AND LOW-DOSE ASPIRIN, Clinical and applied thrombosis/hemostasis, 1(4), 1995, pp. 286-292